Keynote Lectures 2019

WEDNESDAY, 04 DECEMBER 2019

What a vascular specialist needs to know about the management of vascular malformations

Iris Baumgartner, Bern, Switzerland

Wednesday, 04 December 2019 | 13.00-14.05 | VEN 1 | Lecture Hall B

Iris Baumgartner is professor for Internal Medicine with focus on Vascular Medicine. Her particular research interst is in endovascular therapy, congenital vascular malformation and precision medi-cine with translation to vascular medicine.
She graduated in human medicine at the University of Hannover, Germany, in 1986 and was trained in Internal Medicine & Vascular Medicine at the University Hospital Zurich (Switzerland), Düsseldorf (Germany) and Bern (Switzerland) between 1987-94 followed by research fellowships joining the groups of Professor Th. Lüscher (Bern, Switzerland, 1996) and Professor JM. Isner (Boston, USA, 1996/97). Since 2006, she has been Director of the Division Angiology, Swiss Cardiovascular Center, at the Inselspital, University Hospital Bern and since 2012 Vice-Dean of the Medical Faculty at the University Bern.
Iris Baumgartner dedicates herself to the diagnosis and interventional treatments of congenital vas-cular malformations as part of the spectrum of rare vascular diseases. The “Interdisciplinary Center for Vascular Interventions”, at the Inselspital, University Hospital Bern, was established on her ini-tiative in 2009. Development of vascular research at the University Hospital Bern is coordinated by an independent “Clinical Investigation Unit, Vascular Medicine” and supported by an “International Advisory Board”.
Iris Baumgartner is member of various Editorial Boards (JACC, EHJ). Since 1990, she has published 297 articles (207 articles in peer-reviewed medical journals), her h-index is 43 for a total number of 16’612 citations overall.

 

Complications of foam sclerotherapy and lessons learned from the treatment of varicose veins with ablation techniques

Athanasios Giannoukas, Larissa, Greece

Wednesday, 04 December 2019 | 14.30-15.40 | VEN 2 | Lecture Hall B

Giannoukas Athanasios, MSc, MD, PhD, FEBVS (born in Larissa on 01/11/1961) is Professor of Vascular Surgery, Faculty of Medicine, University of Thessaly, Greece and Founder & Chairman of the Department of Vascular Surgery, University Hospital of Larissa, Greece. He is also Dean of the Faculty of Medicine, School of Health Sciences, University of Thessaly in Larissa, Greece (2018-2020).
Prof. A. Giannoukas is Founding Member of the European Venous Forum, Secretary General (2000-2017) & President (2017-2018) and President of the Balkan Venous Forum (2016-2019). Member of the Editorial Board of EJVES (2005-2010), International Angiology (2012-today), Journal of Endovascular Therapy (2012-today). Councilor of ESVS (2014-2016). He is an Honorary Member of the Serbian Society for Cardiovascular Surgery (2018).
He is Founding Member and Chairman of Institute of Vascular Diseases (IVD) Greece (2010-today) and Chairman of Advisory Committee in the organization of LIVE Symposium.
Prof. A. Giannoukas is Director of 2 MSc courses of the University of Thessaly: “Advanced Ultrasonic Functional Imaging And Research for Prevention and Diagnosis of Vascular Diseases” (2015-today) and “Deontology and Ethics in Biomedical Sciences” (2019).
He has over 240 publications (citations: 3924 & H-index: 34) in scientific journals and has written and edited 6 books and 37 book chapters.
He has participated in several research programs as Principal Investigator (13) and supervisor in 9 Doctoral Theses (5 completed), member of Guidelines Committees (5), reviewer in international scientific journals (19) and has been visiting professor in 5 universities (Europe and USA).
He has received 24 prizes, awards, and scholarships.

 

Clinical and genetic determinants of varicose veins

Nicholas Leeper, Palo Alto, United States

Wednesday, 04 December 2019 | 14.30-15.40 | VEN 2 | Lecture Hall B

Dr. Leeper is currently Professor of Surgery (Vascular) and Medicine (Cardiovascular) at Stanford University, where he serves as the Chief of Vascular Medicine and Director of Vascular Research. He holds degrees with honors in Chemistry and Medicine from the University of Chicago, received residency training in Internal Medicine at the University of California, San Francisco, and completed advanced fellowships in Cardiology and Vascular Medicine at Stanford University.
Dr. Leeper is a clinically-active physician-scientist who is interested in the genetic determinants of cardiovascular disease. His laboratory predominantly focuses on atherosclerosis, and understanding why the immune system allows diseased cells to accumulate in the vulnerable plaque. His research is translational in nature, and focuses on advancing discoveries from bench-to-bedside for patients affected by heart attack and stroke.
Outside of Stanford, Dr. Leeper is actively involved in the American Heart Association, having served as the President of the Silicon Valley Board, the leader of several community-based wellness initiatives, and a member of the leadership of both the ATVB and PVD councils. He also is a Trustee of the Society for Vascular Medicine and is the incoming Vice Chair of the Gordon Research Conference on atherosclerosis.

 

Civilian and pediatric vascular trauma management – an overview

Alun Davies, London, United Kingdom

Wednesday, 04 December 2019 | 15.45-16.35 | VEN 3 | Lecture Hall B

Professor Alun H Davies MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, FFST. He is Professor of Vascular Surgery at Imperial College London and a Consultant Surgeon whose NHS practice is based at Charing Cross and St Mary‘s Hospital, London. Professor Davies trained in Cambridge, Oxford, Plymouth, Harvard (USA) and Bristol, prior to taking up a Consultant appointment in Charing Cross in 1994. Professor Davies is regarded as a world expert in the management of vascular (arterial/venous) disorder. He is the Editor in Chief of Phlebology, past President of the European Venous Forum & The Venous Forum at The Royal Society of Medicine . He is a Member of the American Venous Forum, the American College of Phlebology, Vascular Surgical Society of Great Britain and Ireland, European Society of Vascular Surgery. He has been a Hunterian Professor at the RCS, England and is an Emeritius Fellow of the Australasian College of Phlebology. He was the Chairman of the Varicose Vein Guideline Group for the NICE (National Institute of Clinical Excellence) and a member of the Quality Standards Group. He is a member of the NICE guidelines group on AAA. He is a member of the national CRG for vascular surgery and a member of the National Specialized Services Commissioning Panel. He is a director of the European College of Phlebology and has co-chaired the ESVS guidelines group on the management of varicose veins. He has also written extensively on many aspects of vascular disease, writing over 475 peer reviewed manuscripts and runs a large research group. Clinically he runs a tertiary vascular surgical practise and is the Clinical Director of Imperial Private Health, the 2rd largest PPU in the NHS.

 

The management of venous thromboembolism in patients with cancer

Rupert Bauersachs, Darmstadt, Germany

Wednesday, 04 December 2019 | 17.00-18.30 | VEN 4 | Lecture Hall B

Professor Rupert Bauersachs was appointed Director of the Department of Vascular Medicine at the Klinikum Darmstadt GmbH, Germany, in 2003.
Professor Bauersachs received his medical degree from the University of Munich, was a Postdoctoral Fellow at the Department of Pharmacology, University of Munich, and subsequently a Research Fellow of the American Heart Association (AHA) at the Department of Physiology at the University of Southern California (USC), USA. Professor Bauersachs completed his residency in Internal Medicine at the München-Bogenhausen Hospital and the Universities of Mainz and Frankfurt. He is certified for Internal Medicine, Vascular Medicine, Haemostaseology, Diabetology, Phlebology, and Aviation Medicine. His main research interests include venous thromboembolism (VTE), thrombophilia, heparin-induced thrombocytopenia, microcirculation, antithrombotic agents and women’s issues in thrombosis.
Professor Bauersachs became a faculty member of the University of Frankfurt and Head of the Department of Vascular Medicine at the University of Frankfurt in 1999. Since 2012, he has a Professorship for Vulnerable Individuals and Populations in Thrombosis and Hemostasis (VIP-TH) at the Center for Thrombosis and Hemostasis (CTH) at the University of Mainz, Germany. Professor Bauersachs is a council member for the German Societies of Angiology and Phlebology and is active in various other societies for Vascular Medicine and Thrombosis and Haemostasis. He has also published more than 100 original papers, and his scientific work has received several prizes.

 

THURSDAY, 05 DECEMBER 2019

The evolution of branched and fenestrated endografts for TAAA – lessons learned

Gustavo Oderich, Rochester, United States

Thursday, 05 December 2019 | 09.35-11.10 | AOR 2 | Lecture Hall B

Gustavo S. Oderich, M.D. is Professor of Surgery at the Mayo Clinic College of Medicine. He is the Chair of the Division and Program Director for Vascular and Endovascular Training Programs. He is board certified in General and Vascular Surgery. He has completed his training in General and Vascular Surgery at the Mayo Clinic. Subsequently he completed additional training at the Cleveland Clinic. He serves as Associate Editor of the Annals of Vascular Surgery and is reviewer or ad hoc reviewer of 34 medical and surgical journals. His bibliography includes over 618 peer-reviewed articles, book chapters, editorials, or abstracts. He is the editor of two books on mesenteric artery disease and complex endovascular repair. He has delivered 485 presentation in national and international meetings. He has trained 50 clinical and research students and fellows. He serves as principal investigator in over 20 industry and physician sponsor clinical trials and is the National Principal Investigator for the Cook Zenith Fenestrated Plus and the Cook Thoracoabdominal Branch Stent-Graft trials. His areas of interest are complex aortic pathology, fenestrated and branched stent grafts, and mesenteric revascularization.

Novel approaches to endoleaks after EVAR

Alan Lumsden, Houston, United States

Thursday, 05 December 2019 | 11.30-13.00 | AOR 3 | Lecture Hall B

Dr. Lumsden grew up in Whitburn, West Lothian, Scotland, a town of a little more than 10,000 people located between Glasgow and Edinburgh. He received his Bachelor of Medicine from the University of Edinburgh where he graduated at the top of his class. After completing a year-long internship, he moved to Emory University in Atlanta where he completed his general surgery residency and vascular fellowship, and eventually became the Chief of the Division of Vascular Surgery. In 2002, he joined the Michael E. DeBakey Department of Surgery at Baylor College of Medicine as Professor and Chief of the Division of Vascular Surgery and Endovascular Therapy. He assumed his position as Medical Director of the Houston Methodist DeBakey Heart & Vascular Center and Professor & Chairman, Department of Cardiovascular Surgery in 2008.
“I honestly thought I would never leave Emory, but when the chance to work with Dr. DeBakey came along, I thought it was a great opportunity for me,” Lumsden said. “The history of cardiovascular surgery really began here with him and Dr. Stanley Crawford, and I wanted to be a part of this great organization.”
Dr. Lumsden has developed an international reputation as a leader in the fields of endovascular surgery, in the arena of advanced interventional cardiovascular imaging, new educational techniques in vascular surgery, inter-industry collaborations, complex aortic disease, and endovascular robotics.
He has received funding for his research from the National Institutes of Health and industry, and has contributed to more than 400 articles in peer-reviewed journals; as well as abstracts, and authored numerous book chapters. Dr. Lumsden has also been an editor for textbooks related to vascular surgery. He has a particular interest in cardiovascular education and has successfully grown DeBakey Education into a nationally prominent organization.
EDUCATION & TRAINING
• Emory University
• University of Edinburgh

 

The mystery of type II endoleaks – will they ever be prevented?s

Jean-Pierre Becquemin, Creteil, France

Thursday, 05 December 2019 | 11.30-13.00 | AOR 3 | Lecture Hall B

Vascular Surgeon, Institut Vasculaire PARIS Est, Hôpital Paul d Egine Champigny sur Marne 94500 France
Former Head of the Vascular Unit and of the Cardio Vascular Department of Henri Mondor Hospital , Creteil
Professor of Vascular Surgery, University Paris Est Créteil France ( UPEC )
Member of the Major International Vascular Societies : ISVS, SVS, ISET,ISCVS, SCVS
Author/co author of 310 publications in International Journals
Chairman of CACVS , International Meeting in Paris France since 1992
Main Interests : Carotid surgery , Aortic Aneurysms , Peripheral Vascular Diseases

 

The ESVS guidelines on acute limb ischaemia – what is new?

Martin Björck, Uppsala, Sweden

Thursday, 05 December 2019 | 15.30-16.40 | PAD 3 | Lecture Hall B

Professor of Vascular Surgery, Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University, Sweden.
Publication of >200 original articles, >100 review articles, guidelines and book-chapters: 288 “hits” in Pub Med. Hirsch index = 46, 12 cited >100 times. Supervisor of 19 PhD students who completed their thesis, plus seven that are underway. Co-author of 8 clinical practice guidelines.
Main research interests are aortic aneurysm (translational research, epidemiology, treatment), mesenteric vascular disease, vascular trauma, carotid artery disease and acute limb ischaemia.
Senior editor of the European Journal of Vascular and Endovascular Surgery. Past president of the European Society of Vascular Surgery 2016-2017. One of the founders of Vascunet international registry collaboration in 1997, and was its chairman 2003-2006.
MB has a long experience of open and hybrid surgery of uncommon vascular surgical pathology, such as paraganglioma of the neck, vascular TOS, mesenteric ischaemic conditions, popliteal entrapment syndrome, and pediatric vascular problems.

 

Keynote lecture 1:
Rationale and background of the AAA guidelines of the NICE institute (UK)

Andrew Bradbury, Birmingham, United Kingdom

Thursday, 05 December 2019 | 13.50-15.15 | AOR 4 | Lecture Hall B

Keynote lecture 2:
Key recommendations from the Global Vascular Guideline on GVG on critical limb-threatening ischaemia

Andrew Bradbury, Birmingham, United Kingdom

Thursday, 05 December 2019 | 16.45-18.15 | PAD 4 | Lecture Hall B

“Professor Andrew Bradbury took up post as the Sampson Gamgee Professor of Vascular Surgery, University of Birmingham, and Honorary Consultant Vascular Surgeon at Heartof England (now University Hospitals Birmingham) NHS Foundation Trust, in January 2000 having previously worked as an academic Consultant Vascular Surgeon at the University of Edinburgh since 1995. Andrew Chairs the NIHR HTA Hospital-based Care Committee and is also a member of the NIHR HTA Programme Oversight Committee. Andrew also is Chairing the NICE Abdominal Aortic Aneurysm (AAA) national Guideline Committee (GC). Recent publication highlights include the NIHR HTA funded EVRA trial results in the NEJM and publication of the Global Vascular Guidelines (GVG) on Chronic Limb Threatening Ischaemia (CLTI) in the JVS and EJVES. The long-term results of the NIHR HTA funded EVRA trial, and the main results of the NIHR HTA funded GAPS trial, have been submitted for publication. Andrew is Chief Investigator for the NIHR HTA funded BASIL 2 and BASIL 3 trials. Both trials ate very close to 85% recruitment. Andrew is a co-applicant on the NIHR HTA funded CHAPS trial which will start randomising patients later this year. Andrew now Chairs the Scientific Committee, and sits on the Executive Committee of, the International Union of Phlebology (IUP); and has been appointed Associate Editor (IUP affairs) of the journal Phlebology. Andrew continues to sit on the Council of the World Federation of Vascular Societies”

What ABI and TBI tell us about the outcomes of PAD and how clopidogrel and statins influence that

Maarit Venermo, Helsinki, Finland

Thursday, 05 December 2019 | 12.00-13.00 | PAD 1 | Lecture Hall C

Current position: Professor of Vascular Surgery, Head of the Department, Helsinki University Hospital, University of Helsinki

Scientific merits: 141 original articles, 111 editorials, reviews, guidelines or textbook chapters, 10 supervised (compleded) PhDs ans 7 ongoing PhD supervisions

Main areas of research interest:

  • Registry studies aiming to evaluate the quality of vascular surgical service as well as international variation in practice
  • Critical limb ischemia, evaluation of perfusion in chronic limb ischemia, angiosome consept in CLTI
  • Epidemiology and natural history of aortoiliac aneurysms
  • Natural history and surveillance of AAAs after EVAR
  • Natural history of the patients with peripheral arterial disease, the predictive value of ABI and toe pressure, influence of antithrombotic agents and statins to the prognosis
  • Aortic graft infections and mycotic aneurysms, treatment, pathogens, infection resistence of different graft materials
  • Pathobiology of the peripheral arterial disease

Positions in trust:

  • Finnish Society for Vascular Surgery, President 2004-2008
  • Finnish Surgical Society, Councillor, 2004-2008
  • European Society for Vascular Surgery, Councillor 2005-2008
  • Vascunet, Vascular Quality Improvement Group of ESVS, National Delegate 2004, Chair 2013-2016;
ICVR), member of the board 2013 European chair 2017
  • Division for Vascular surgery / Section for Surgery / U.E.M.S. National Delegate 2012
  • Seceretary general elected of the European Society for Vascular Surgery
  • Editoreal board member European Journal of Vascular and Endovascular Surgery 2012

FRIDAY, 06 DECEMBER 2019

Future perspectives of drug-eluting technologies, atherectomy, and intravascular lithotrypsy

Gunnar Tepe, Rosenheim, Germany

Friday, 06 December 2019 | 08.30-10.15 | PAD 5 | Lecture Hall B

Gunnar Tepe is a professor of radiology with special focus on interventional radiology. His particular research interest is endovascular therapy.

He graduated in human medicine at the Free University of Berlin, Germany in 1993, afterwards he started his medical career at the University at Tuebingen where he became the degree of Diagnostic Radiology in 2001. In 2003 he was elected as professor of Radiology. In the department of Diagnostic and Interventional Radiology Dr. Tepe was the head of the Laboratory of Experimental Interventional Radiology since 1997. He led the interventional section in the department of radiology at the University of Tuebingen for more than 5 years and started several clinical studies in that time which he also led as a PI. One of his landmark trials was the Thunder study. It was the first human usage of drug-coated-balloons in patients with peripheral arterial disease. The data of that study were published in the New England Journal of Medicine. In 2003 Prof. Tepe received the Konrad Wilhelm Roentgen Price.

In 2009 Prof. Tepe moved to the RoMed Clinic Rosenheim and became the head of the Department of Diagnostic and Interventional Radiology. Since that time he participated and also organized further clinical studies such as InPact SFA, Copa Cabana, Sports, Samba and Biolux PI, II and III. From 2009 to 2019 he was a part of the organizing committee of Angio Update and since 2017 Prof. Tepe is a member of the Charing Cross Executive Board. He is also a board member of several societies. He is reviewer in several Pubmed listed journals such as JACC Intervention, Circulation and the Journal of Endovascular Therapy. Since 2017 Professor Tepe serves as the section editor endovascular in CVIR.

Do “real-world” data confirm differences in mortality after PAD treatment with paclitaxel-coated devices?

Christian Behrendt, Hamburg, Germany

Friday, 06 December 2019 | 08.30-10.15 | PAD 5 | Lecture Hall B

Dr Christian-Alexander Behrendt (MD, Doctor of Medicine) is member of the European Society for Vascular Surgery (ESVS) and elected member of the Society of Vascular Surgery (SVS). In 2019, he was elected as SVS International Scholar. Christian is head of the research group GermanVasc (Cardiovascular Health Services Research, www.germanvasc.de) at the University Medical Center Hamburg-Eppendorf (UKE) and works as vascular surgeon at the Department of Vascular Medicine, Hamburg, Germany. His working group GermanVasc currently has a research budget of approximately 7 million euros and employs four full time scientists and statisticians. Between 2014 and 2019, Christian became an expert in real-world-evidence research using health insurance claims data for vascular research and quality improvement. His main field of interest is cardiovascular health services research, real-world-evidence, big data, and comparative outcome research.
Christian is founding member of the International Consortium of Vascular Registries (ICVR, established in 2015) and the Medical Device Epidemiology Network (MDEpiNet), where he serves as Co-Chair of the German Chapter. Since 2017, he is secretary of the VASCUNET committee of the ESVS.

Keynote lecture 1:
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose

Peter Rothwell, Oxford, United Kingdom

Friday, 06 December 2019 | 10.30-12.10 | CAD 4 | Lecture Hall B

Keynote lecture 2:
Is the epidemiology of carotid-related cerebral ischaemia really changing?

Peter Rothwell, Oxford, United Kingdom

Friday, 06 December 2019 | 15.30-17.00 | CAD 6 | Lecture Hall B

Peter Rothwell is the Action Research Professor of Neurology at Oxford University and Founding Director of the Wolfson Centre for Prevention of Stroke and Dementia (CPSD). His research group, which includes about 40 staff, studies the causes of stroke and strategies for improving prevention. Rothwell has published over 500 research papers and has been the recipient of many awards, including the Queen’s Anniversary Prize for Higher and Further Education.

What did we learn from the German Carotid Registry

Andreas Kühnl, Munich, Germany

Friday, 06 December 2019 | 13.30-15.05 | CAD 5 | Lecture Hall B

Andreas Kuehnl, MPH, MBA, is a vascular surgeon and leader of a research group at the Department for Vascular and Endovascular Surgery, University Hospital rechts der Isar in Munich (Prof. H.-H. Eckstein), which focus on the analysis of real-world data. Between 2016 and 2019, he was head of project management, and personal assistant to the Chief Executive Officer of the University Hospital rechts der Isar (Prof. M. Schwaiger).
The main research topics of Professor Kuehnl are secondary data analyses of the nationwide quality assurance registry for CEA and CAS, and the German hospital episodes DRG database. The particular emphasis of research is on volume-outcome relationship, spatial interaction, and regional differences regarding the epidemiology, treatment, and outcome of surgery for aortic aneurysm, aortic dissection, carotid stenosis, and acute mesenteric infarction.
Since 2009, he is also secretary of the steering group for the first edition and (since 2015) the update of the German-Austrian S3-Guideline for the diagnosis, treatment and follow-up of extracranial carotid stenosis. In addition, Andreas Kuehnl contributed to a subgroup analysis of the Carotid Stenosis Trialists Collaboration, to a Cochrane review on leadership interventions, and a couple of studies on vascular biology

PET-CT – an important tool to detect small AAAs with an increased rupture risk and to predict complications after EVAR

Natzi Sakalihasan, Liège, Belgium

Friday, 06 December 2019 | 10.30-12.10 | AOR 6 | Lecture Hall C

Professor Natzi Sakalihasan is a cardiovascular and thoracic surgeon and the director of the “Center of the research and experimental surgery” (CREDEC) at the University of Liege (ULg), GIGA cardio-vascular sciences Liege, Belgium. He received his medical school diploma from Cerrahpasa medical school of the University of Istanbul, and its equivalence from University of Liege. From 1986 up to date, Natzi Sakalihasan is working as cardiovascular surgeon in the department of cardiovascular and thoracic surgery at the University Hospital of Liege. He defended his PhD and Aggregation thesis on aortic aneurysms in 1994 and 2005, respectively and since 2013, he has also been working as a lecturer at ULg where he teaches the biology of vascular walls. Professor Sakalihasan authored/coauthored about 120 scientific papers including about 60 papers on abdominal aortic aneurysms. His interest in research focused specially on the all aspect of abdominal aortic aneurysm and functional imaging of the aortic diseases. He is director of International meeting on aortic diseases (IMAD),Liege – Belgium, Founder of the Aneurysmal Pathology Foundation (APF), published in the Moniteur Belge in 2010. Co-founder of WGF (Wellness Global Foundation), Colorado, USA, October 2007.